GSK Statement in Response to Vote on Availability of Avandia

barbara.lempert GSK Statement in Response to FDA Advisory Committee’s Vote on Availability of Avandia (Rosiglitazone) PHILADELPHIA, June 6, 2013 – GlaxoSmithKline [NYSE: GSK] ...

Physicians can count on QuantiaMD and Hudson Global’s ON Network

mia.burns By Mia Burns (mia.burns@ubm.com) QuantiaMD and Hudson Global, a division of Draftfcb Healthcare, announced today a new and innovative partnership that will deliver active ...

Study: Physicians Insufficiently Informed of Drug Side Effects

barbara.lempert An international study involving 255 physicians practising in Vancouver, Montreal, Sacramento and Toulouse found that physicians are not given enough information about ...

As Forest CEO Plans Retirement, The Feds Issue A New Subpoena

esilverman Around the same time that Howard Solomon decided that he will soon retire as the long-standing ceo at Forest Laboratories, the drugmaker received a subpoena from the US ...

EU OKs Stribild for HIV

barbara.lempert European Commission Approves Stribild, a New Single Tablet Regimen for the Treatment of HIV-1 Infection FOSTER CITY, Calif.–(BUSINESS WIRE)–May. 28, 2013– ...

Actavis Says Court Blocks Generic Pulmicort

barbara.lempert PARSIPPANY, N.J., May 24, 2013 (AP) — Actavis Inc. said Friday a federal appeals court granted an injunction that blocks it from selling a generic version of AstraZeneca ...

Novartis Probes Researcher’s Employment Status

barbara.lempert Drug maker staff found to have joined research without identifying OSAKA, May 24 — (KYODO) _ An employee of Novartis Pharma K.K. is found to have participated ...

Alkermes Posts 4Q Profit As Royalty Payments Rise

barbara.lempert NEW YORK, May 24, 2013  (AP) — Alkermes PLC said Thursday that it was profitable in its fiscal fourth quarter as it received bigger royalty payments and more revenue ...

Merck Stops Development of Phase III Parkinson’s Drug

barbara.lempert Merck Provides Update on Phase III Clinical Program for Preladenant, the Company’s Investigational Parkinson’s Disease Medicine WHITEHOUSE STATION, N.J.–(BUSINESS ...

Up And Down The Ladder… Job Changes

esilverman Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send ...

Steve Nissen: The FDA Meeting On Avandia Will Be A ‘Whitewash’

esilverman Next month, the FDA will hold a two-day meeting to discuss the results of a clinical trial for the Avandia diabetes pill, three years after the agency greatly restricted ...

Jury hits Takeda with $6.5M judgment in first Actos liability case

Tracy Staton Score one for the plaintiffs in Takeda Pharmaceuticals’ Actos litigation. A California jury weighed in against the drugmaker, deciding that Takeda didn’t do ...
Page 1 of 2212345...1020...Last »
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS